Home-Based Monitoring in Parkinson's Disease

NCT ID: NCT06573762

Last Updated: 2025-04-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-07

Study Completion Date

2028-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to learn about the usefulness of automated analysis of speech, physical activity measures tracked using wearable devices at home, and tremor detection measured using computer-vision analysis of smartphone video to detect impairments related to Parkinson's disease and improve prediction of one-year progression.

Participants will attend a short research visit at the University of Iowa. During this visit, they will make a video recording using a smartphone of them performing a fine motor task and audio recordings of pre-written text. They will be provided with an activity tracker and asked to wear it at home for four weeks. After four weeks, a video visit will be conducted and the speech and video tasks will be repeated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Two groups of participants will be recruited. Group 1 will be patients newly referred to the Movement Disorders clinic for evaluation of possible Parkinson's disease. Group 2 will be patients with a recent (within 6 months) diagnosis of Parkinson's disease.

Group 1 (Newly Referred) will attend a baseline visit where the following data will be collected:

* Unified Parkinson's Disease Rating Scale (UPDRS). The motor assessment tasks will be recorded using an iPad.
* Montreal Cognitive Assessment (MoCA).
* Cognitive function assessment using NIH Toolbox.
* Diagnosis made at the Movement Disorders Clinic (PD or not PD).
* SF-20 quality of life assessment. (Short Form 20)
* PDQ-39 quality-of-life assessment. (Parkinson's Disease Questionnaire 39)
* Tongue and lip strength using the Iowa Oral Pressure Instrument.
* Cognitive function assessment using NIH Toolbox.
* Audio recordings of:

* Diadochokinesis (DDK) assessment.
* Vowel prolongation assessment.
* Sentence Intelligibility Test.
* Reading the Grandfather, Bamboo, and Rainbow passages.
* Recording of conversational speech.

Participants will be provided with an activity tracker and a research team member will help install any required apps on the participant's phone, configure and connect the activity tracker, provide a basic overview of how the app and tracker work, and answer any additional questions the participant may have.

The participant will then wear the activity tracker at home for 4 weeks. Text messages reminders will be sent following days with non-wear (no recorded heart rate or steps for multiple hours throughout the day) as a reminder to increase wear time.

At 4 weeks, the participant will complete a video visit using Microsoft Teams/Zoom with a study team member and the study participant. During the video visit, a recording of three different fine-motor skill tasks used in the UPDRS will be made. During the call, the study team member will provide coaching and direct the participant to repeat the audio and UPDRS fine motor task assessment at home while recording the video visit. At the end of the video visit, research team member will also collect questions about the ease and willingness to use the activity tracker and video call for disease monitoring and any open-ended comments the participant wishes to provide. This concludes the participants involvement in the study.

Group 2 (Recently Diagnosed) will attend a baseline visit where the following data will be collected:

* Unified Parkinson's Disease Rating Scale (UPDRS). The motor assessment tasks will be recorded using an iPad.
* Montreal Cognitive Assessment (MoCA).
* Cognitive function assessment using NIH Toolbox.
* Diagnosis made at the Movement Disorders Clinic (PD or not PD).
* SF-20 quality of life assessment.
* PDQ-39 quality-of-life assessment.
* Tongue and lip strength using the Iowa Oral Pressure Instrument.
* Cognitive function assessment using NIH Toolbox.
* Audio recordings of:

* Diadochokinesis (DDK) assessment.
* Vowel prolongation assessment.
* Sentence Intelligibility Test.
* Reading the Grandfather, Bamboo, and Rainbow passages.
* Recording of conversational speech.

Participants will be provided with an activity tracker and a research team member will help install any required apps on the participant's phone, configure and connect the activity tracker, provide a basic overview of how the app and tracker work, and answer any additional questions the participant may have.

The participant will then wear the activity tracker at home for 4 weeks. Text messages reminders will be sent following days with non-wear (no recorded heart rate or steps for multiple hours throughout the day) as a reminder to increase wear time.

At 4 weeks, the participant will complete a video visit using Microsoft Teams/Zoom with a study team member and the study participant. During the video visit, a recording of three different fine-motor skill tasks used in the UPDRS will be made. During the call, the study team member will provide coaching and direct the participant to repeat the audio and UPDRS fine motor task assessment at home while recording the video visit. At the end of the video visit, research team member will also collect questions about the ease and willingness to use the activity tracker and video call for disease monitoring and any open-ended comments the participant wishes to provide.

At 11 months, the participant will be contacted to schedule a one-year research visit. Many patients return on 3-6 month intervals to the UIHC Movement Disorders Clinic and the research visit will ideally coordinate the participants routine visit for care.

At the one-year encounter, which will be an in-person research visit, the following data elements will be collected:

* Unified Parkinson's Disease Rating Scale (UPDRS).
* Montreal Cognitive Assessment (MoCA).
* Cognitive function assessment using NIH Toolbox.
* SF-20.
* PDQ-39 quality-of-life assessment.

Additionally, the research team will solicit any open-ended feedback the participant wants to share with the study team about their experience being in the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Recently Referred for Possible Parkinson's Disease

Patients referred to the University of Iowa Hospitals and Clinics (UIHC) Movement Disorders Clinic for possible Parkinson's disease.

No interventions assigned to this group

Recently Diagnosed with Parkinson's Disease

Patients of the UIHC Movement Disorders Clinic with a recent (less than 6 months) diagnosis of Parkinson's disease.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1\. Newly referred to UIHC Movement Disorders Clinic


1. Patient of UIHC Movement Disorders Clinic
2. Diagnosed with Parkinson's disease

Exclusion Criteria

1. Prior diagnosis of Parkinson's disease
2. Confined to wheelchair or bed
3. Non-English speaking
4. Prisoner status
5. Inability to provide own informed consent
6. Phone unable to support the Fitbit app

Group 2: People with a recent diagnosis of Parkinson's disease


1. First diagnosed \> 6 months ago
2. Confined to wheelchair or bed
3. Non-English speaking
4. Prisoner status
5. Inability to provide own informed consent
6. Phone unable to support the Fitbit app
Minimum Eligible Age

50 Years

Maximum Eligible Age

110 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jacob E. Simmering

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jacob E. Simmering

Assistant Professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jacob Simmering, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Iowa

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Iowa Hospitals and Clinics

Iowa City, Iowa, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jacob Simmering, MS, PHD, BA

Role: CONTACT

3196788037

Shelby Francis, PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jacob Simmering, PhD

Role: primary

3196788037

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

202308199

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.